ADVFN US – Market Content Editor
-

Peraso Shares Slip as Company Considers Strategic Alternatives
Shares of Peraso Inc. (NASDAQ: PRSO) declined 3% after the mmWave wireless technology firm revealed its board of directors has initiated a review of strategic alternatives aimed at boosting shareholder value. The company is weighing a range of possibilities, including a potential merger, asset sale, or other types of business combinations. To guide the process,…
-

Gorilla Technology Shares Edge Higher on $5.6 Billion Opportunity Pipeline
Gorilla Technology Group Inc. (NASDAQ:GRRR) saw its stock climb 2.3% after the AI-driven solutions provider unveiled a detailed business update, spotlighting an active deal pipeline valued at $5.6 billion across 87 separate opportunities. The company projects closing approximately $1.3 billion in contracts by mid-2026. These will be secured through multi-year agreements ranging from three to…
-

Mogo Shares Climb After Strategic Stake in Digital Commodities Capital
Mogo Inc. (NASDAQ:MOGO) saw its stock rise 4.5% following the Canadian fintech’s strategic investment in Digital Commodities Capital Corp. (CSE: DIGI). Mogo disclosed it has acquired close to a 9% ownership interest in Digital Commodities, a publicly traded investment issuer focused on holding Bitcoin and physical gold. The $1 million investment was made through Digital…
-

Milestone Pharmaceuticals Shares Drop Sharply After Public Offering Announcement
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) saw its stock plunge 30% following the announcement of a planned underwritten public offering involving common shares and warrants. The biopharma firm revealed it intends to issue common stock alongside Series A and Series B warrants to buy additional shares, as well as pre-funded warrants paired with warrants for select investors.…
-

MicroCloud Hologram Shares Jump 30% Following $200 Million Bitcoin Investment Announcement
Shares of MicroCloud Hologram Inc. (NASDAQ:HOLO) surged by 30% after the tech services firm revealed plans to invest up to $200 million in Bitcoin and cryptocurrency-linked securities and derivatives. As of July 11, the company reported cumulative investment gains totaling $34.02 million from these ventures. MicroCloud holds robust cash reserves amounting to $394 million, earmarked…
-

Dow Jones, S&P, Nasdaq, Wall Street Set for Lower Open Amid Renewed Tariff Fears
U.S. stock markets are poised to open lower on Friday as futures for the major indexes signal a retreat, with investors bracing for renewed trade tensions following two days of gains. The pullback comes in response to rising anxiety over President Donald Trump’s latest trade actions, which have refocused attention on his increasingly aggressive tariff…
-

Robinhood Under Florida Investigation for Alleged Misleading Crypto Pricing Claims
Florida’s attorney general has launched an investigation into Robinhood Crypto (NASDAQ:HOOD), LLC, probing whether the platform misled users about the true cost of trading digital assets. The inquiry centers on suspicions that Robinhood’s promotional messaging may have violated state consumer protection laws. Attorney General James Uthmeier announced Thursday that his office has issued a subpoena…
-

MiNK Therapeutics Shares Skyrocket After Landmark Cancer Remission Result
MiNK Therapeutics, Inc. (NASDAQ:INKT) saw its stock soar by 200% following the announcement of a remarkable cancer remission case linked to its investigational cell therapy, agenT-797. The clinical-stage biotech firm revealed that a patient with advanced, treatment-resistant testicular cancer achieved full remission after receiving a single infusion of its allogeneic invariant natural killer T (iNKT)…
-

Gauzy Shares Rally After CEO and Key Investor Snap Up Over Half a Million Shares
Gauzy Ltd. (NASDAQ:GAUZ) stock surged 20% after the company disclosed that CEO and Co-Founder Eyal Peso and major investor Alejandro Weinstein acquired a combined 560,000 ordinary shares in a private deal. The purchase, finalized in the first half of June 2025, involved shares bought from an existing shareholder. The move is being interpreted as a…
-

Capricor Shares Tumble After FDA Rejects Duchenne Therapy Application
Capricor Therapeutics (NASDAQ:CAPR) saw its stock plummet by 53% on Friday after the U.S. Food and Drug Administration issued a Complete Response Letter (CRL), rejecting the company’s bid for approval of its Duchenne muscular dystrophy (DMD) therapy, Deramiocel. The agency stated that the company’s Biologics License Application (BLA) lacked the required substantial evidence to demonstrate…